Moolec Science SA (MLEC) Form 6-K — May 13, 2026
Moolec Science SA has successfully regained compliance with Nasdaq's continued listing requirements within the remediation period granted by the Nasdaq Hearings Panel. The company reported stockholders' equity of approximately $15.2 million as of March 31, 2026, up from $11.3 million as of December 31, 2025. This financial improvement is reflected in the unaudited interim condensed consolidated financial statements. The company also announced a proforma adjustment related to disbursements made from its current line of credit with a related party, amounting to $465,161 in April 2026.
Key figures
- Total Assets
- 104.2
- Total Liabilities
- 88.2
- Cash And Equivalents
- 1.2
- Stockholders Equity
- 15.2
- Stockholders Equity Yoy
- 11.3
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.